AstraZeneca's Experimental COVID-19 Drug, a Cocktail of Two Antibodies, is the First of ... - Latest Tweet by Reuters

AstraZeneca's experimental COVID-19 drug, a cocktail of two antibodies, is the first of its kind to show promise at late-stage clinical trials as both a preventative medicine and as treatment for the virus, the British drugmaker said https://t.co/y7UCLNrmhK pic.twitter.com/wcQhCXyP0x— Reuters (@Reuters) October 11, 2021

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)